Monarch Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Monarch Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.37M	Sell	23,815 -150	-0.6%	-$8.61K	0.31%	72
2026 Q1	$1.45M	Sell	23,965 -15	-0.1%	-$874	0.36%	69
2025 Q4	$1.29M	Hold	23,980	–	–	0.32%	67
2025 Q3	$1.08M	Sell	23,980 -475	-2%	-$22.2K	0.27%	70
2025 Q2	$1.13M	Buy	24,455 +47	+0.2%	+$2.31K	0.3%	67
2025 Q1	$1.49M	Hold	24,408	–	–	0.41%	56
2024 Q4	$1.38M	Sell	24,408 -50	-0.2%	-$2.79K	0.38%	58
2024 Q3	$1.27M	Buy	24,458 +230	+0.9%	+$10.8K	0.34%	64
2024 Q2	$1.01M	Sell	24,228 -864	-3%	-$38.7K	0.3%	69
2024 Q1	$1.36M	Sell	25,092 -2	-0%	-$102	0.38%	59
2023 Q4	$1.29M	Sell	25,094 -225	-0.9%	-$11.8K	0.39%	60
2023 Q3	$1.47M	Hold	25,319	–	–	0.47%	53
2023 Q2	$1.62M	Hold	25,319	–	–	0.49%	52
2023 Q1	$1.75M	Hold	25,319	–	–	0.54%	51
2022 Q4	$1.82M	Hold	25,319	–	–	0.56%	51
2022 Q3	$1.8M	Sell	25,319 -96	-0.4%	-$6.96K	0.59%	46
2022 Q2	$1.96M	Sell	25,415 -33	-0.1%	-$2.51K	0.58%	46
2022 Q1	$1.86M	Hold	25,448	–	–	0.49%	51
2021 Q4	$1.59M	Hold	25,448	–	–	0.41%	56
2021 Q3	$1.51M	Hold	25,448	–	–	0.42%	59
2021 Q2	$1.7M	Sell	25,448 -39	-0.2%	-$2.54K	0.49%	55
2021 Q1	$1.61M	Hold	25,487	–	–	0.48%	55
2020 Q4	$1.58M	Sell	25,487 -111	-0.4%	-$6.83K	0.5%	53
2020 Q3	$1.54M	Sell	25,598 -100	-0.4%	-$6.02K	0.54%	48
2020 Q2	$1.51M	Sell	25,698 -1,130	-4%	-$67.6K	0.55%	47
2020 Q1	$1.5M	Sell	26,828 -899	-3%	-$54.9K	0.61%	44
2019 Q4	$1.78M	Buy	27,727 +1,875	+7%	+$107K	0.58%	50
2019 Q3	$1.31M	Hold	25,852	–	–	0.46%	54
2019 Q2	$1.17M	Hold	25,852	–	–	0.42%	54
2019 Q1	$1.23M	Sell	25,852 -100	-0.4%	-$4.98K	0.45%	55
2018 Q4	$1.35M	Sell	25,952 -300	-1%	-$16.1K	0.55%	50
2018 Q3	$1.63M	Sell	26,252 -250	-0.9%	-$14.8K	0.59%	50
2018 Q2	$1.47M	Sell	26,502 -610	-2%	-$32.9K	0.56%	50
2018 Q1	$1.72M	Sell	27,112 -125	-0.5%	-$8.04K	0.66%	48
2017 Q4	$1.67M	Sell	27,237 -1,000	-4%	-$62.5K	0.62%	48
2017 Q3	$1.8M	Hold	28,237	–	–	0.67%	47
2017 Q2	$1.57M	Sell	28,237 -625	-2%	-$34K	0.6%	50
2017 Q1	$1.57M	Sell	28,862 -57	-0.2%	-$3.13K	0.57%	49
2016 Q4	$1.69M	Sell	28,919 -2,750	-9%	-$150K	0.63%	49
2016 Q3	$1.71M	Buy	31,669 +905	+3%	+$58.1K	0.65%	48
2016 Q2	$2.26M	Hold	30,764	–	–	0.84%	42
2016 Q1	$1.97M	Sell	30,764 -645	-2%	-$40.7K	0.71%	48
2015 Q4	$2.16M	Hold	31,409	–	–	0.83%	43
2015 Q3	$1.86M	Hold	31,409	–	–	0.76%	46
2015 Q2	$2.09M	Sell	31,409 -353	-1%	-$23.3K	0.8%	47
2015 Q1	$2.05M	Hold	31,762	–	–	0.77%	46
2014 Q4	$1.88M	Sell	31,762 -400	-1%	-$22.6K	0.71%	47
2014 Q3	$1.65M	Sell	32,162 -130	-0.4%	-$6.49K	0.66%	46
2014 Q2	$1.57M	Hold	32,292	–	–	0.6%	50
2014 Q1	$1.68M	Sell	32,292 -525	-2%	-$27.9K	0.66%	48
2013 Q4	$1.74M	Sell	32,817 -980	-3%	-$49.9K	0.68%	49
2013 Q3	$1.56M	Hold	33,797	–	–	0.66%	49
2013 Q2	$1.51M	Buy	+33,797	New	+$1.47M	0.65%	49

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Monarch Capital Management's BMY Position: Q2 2026 in Review

Monarch Capital Management reduced its Bristol-Myers Squibb (BMY) stake by 0.63% in Q2 2026, selling an estimated $8.61K and leaving 23,815 shares worth $1.37M. The position accounts for 0.31% of the portfolio, ranked #72.

Monarch Capital Management first reported a position in BMY in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.26M in Q2 2016. 887 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Monarch Capital Management held 23,815 shares of Bristol-Myers Squibb worth $1.37M as of Q2 2026.
Monarch Capital Management sold 150 Bristol-Myers Squibb shares in Q2 2026, an estimated $8.61K.
Bristol-Myers Squibb made up 0.31% of Monarch Capital Management's portfolio in Q2 2026, its #72 holding.
Monarch Capital Management first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 53 quarters since.
Monarch Capital Management's Bristol-Myers Squibb position peaked at $2.26M in Q2 2016.
887 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Monarch Capital Management's 13F filing for Q2 2026, filed 22 Jul 2026.